The invention relates to the technical field of eye drops, in particular to a
plant extract-based
eye drop, which is prepared from the following components in parts by weight: 75.00 to 85.00 parts of
hamamelis virginiana leaf water, 75.00 to 85.00 parts of 1, 2, 4-trimethyl-1, 3-pentanediol monoisobutyrate, 75.00 to 85.00 parts of 1, 2, 4-trimethyl-1, 3-pentanediol monoisobutyrate, 75.00 The
traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 4.00 to 8.00 parts of 1, 3-
propylene glycol, 2.00 to 6.00 parts of
rose flower extract, 0.50 to 1.50 parts of
nicotinamide, 0.50 to 1.50 parts of beta-
glucan, 0.50 to 1.50 parts of
lutein, 0.2 to 0.7 part of
sodium chloride, 0.10 to 0.30 part of
sodium hyaluronate, 0.10 to 0.30 part of
allantoin, 0.10 to 0.30 part of
dipotassium glycyrrhizinate, 0.10 to 0.20 part of folium artemisiae argyi extract, 0.10 to 0.20 part of grapefruit fruit extract, 0.10 to 0.20 part of
semen cassiae torae extract and 2.50 to 7.00 parts of
taurine. According to the eye drops based on the
plant extracts, the soothing and astringing characteristics of the
hamamelis virginiana leaf water are fused, and through the synergistic effect of the folium artemisiae argyi extract, the
grapefruit extract and the
semen cassiae extract, eye
metabolism is further improved, the
oxidation resistance of eye tissues is enhanced, and
eye health is promoted.